Immune Response and Cognitive Impairment in Post-COVID Syndrome: A Systematic Review - 18/03/25
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Background |
Altered immune response and cognitive difficulties have been demonstrated in studies of post-COVID syndrome, including differences in immune status and cognitive functioning in the months following infection. This review aimed to examine immune status and cognitive differences in post-COVID syndrome 12 or more weeks after COVID-19 infection. A further aim of this review was to explore a link between immune response and the cognitive deficits observed in this group.
Methods |
A systematic review was carried out using PubMed, PsychInfo, EMBASE, and Web of Science electronic databases of observational studies 12+ weeks after COVID-19 infection, with assessment of immune status and cognitive function in post-COVID syndrome samples. This review protocol was recorded on PROSPERO with registration number CRD42022366920.
Results |
Following eligibility screening, 11 studies met inclusion criteria and were selected for our review. Six of eight studies that examined between-group differences in specific domains suggested impaired cognition in the post-COVID syndrome population, with the domain of executive function particularly affected. Of 11 studies with immune data, 7 studies reported increased markers of inflammation in the post-COVID syndrome group, when compared with an age- and sex-matched “healthy control” sample, or population norms. Finally, when immune function and cognition are examined together, 6 studies presented results indicating a significant association between elevated immune response and cognitive function in post-COVID syndrome.
Conclusion |
This review highlights the frequency of cognitive difficulties months after COVID-19 infection and explores heightened immune response as a predictor of this change. Six studies suggest that immune status is a predictor of cognitive function, examining a marker of immune function and objective cognitive performance at 12 or more weeks following infection. Future studies of cognitive function in post-COVID syndrome are needed to explore this relationship and underlying mechanisms leading to changes in cognitive performance.
El texto completo de este artículo está disponible en PDF.Keywords : Cognition, COVID-19, Immune function, Inflammation, Post-COVID-19 syndrome
Esquema
| Funding: None. |
|
| Conflicts of Interest: None. |
|
| Authorship: All authors contributed to writing this manuscript. JH: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing - original draft, review, & editing; DS: Data curation, Formal analysis, Writing - review & editing; SB: Conceptualization, Writing – review & editing; SO: Conceptualization, Methodology, Project administration, Supervision, Writing - review & editing; SS: Conceptualization, Visualization, Writing - review & editing; FO: Conceptualization, Project administration, Supervision, Writing - review & editing; JB: Conceptualization, Methodology, Project administration, Resources, Supervision, Writing - review & editing. |
Vol 138 - N° 4
P. 698 - avril 2025 Regresar al número
Artículo precedente
- Non-Invasive Brain Stimulation for Post-COVID-19 Conditions: A Systematic Review
- Anna Markser, Jasper Vöckel, Alexa Schneider, Luise Baumeister-Lingens, Christine Sigrist, Julian Koenig
- Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort
- Mitsuaki Sawano, Yilun Wu, Rishi M. Shah, Tianna Zhou, Adith S. Arun, Pavan Khosla, Shayaan Kaleem, Anushree Vashist, Bornali Bhattacharjee, Qinglan Ding, Yuan Lu, César Caraballo, Frederick Warner, Chenxi Huang, Jeph Herrin, David Putrino, Teresa Michelsen, Liza Fisher, Cynthia Adinig, Akiko Iwasaki, Harlan M. Krumholz
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.